XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.631
-0.000 (-0.03%)
At close: Dec 5, 2025, 4:00 PM EST
0.620
-0.011 (-1.73%)
After-hours: Dec 5, 2025, 5:47 PM EST

XORTX Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20 2019 - 2015
Net Income
-1.94-3.31-2.16-7.72-1.58-1.01
Upgrade
Depreciation & Amortization
0.110.120.140.060.010.02
Upgrade
Asset Writedown & Restructuring Costs
-----0.05
Upgrade
Stock-Based Compensation
0.030.120.120.490.460.23
Upgrade
Other Operating Activities
-1.27-0.72-3.66-2.47-2.61-0.14
Upgrade
Change in Accounts Receivable
-0.010.040.02-0.04-0.03-
Upgrade
Change in Accounts Payable
0.06-0.13-1.190.89-0.260.32
Upgrade
Change in Other Net Operating Assets
0.070.210.140.62-0.79-0.03
Upgrade
Operating Cash Flow
-2.95-3.68-6.58-8.17-4.8-0.57
Upgrade
Capital Expenditures
---0-0.02--
Upgrade
Sale (Purchase) of Intangibles
-0.03-0.04-0.04-0.03-0.03-0.01
Upgrade
Investing Cash Flow
-0.03-0.04-0.05-0.05-0.03-0.01
Upgrade
Long-Term Debt Repaid
--0.07-0.07-0.02--
Upgrade
Net Debt Issued (Repaid)
-0.09-0.07-0.07-0.02--
Upgrade
Issuance of Common Stock
2.653.520520.070.71
Upgrade
Other Financing Activities
-0.66-0.67-0.3-1.07-0.7-0.03
Upgrade
Financing Cash Flow
1.92.78-0.363.9119.370.67
Upgrade
Foreign Exchange Rate Adjustments
-0.02-0.040-0.140.2-
Upgrade
Net Cash Flow
-1.11-0.97-6.99-4.4414.740.09
Upgrade
Free Cash Flow
-2.95-3.68-6.59-8.19-4.8-0.57
Upgrade
Free Cash Flow Per Share
-0.75-1.28-3.32-5.53-4.39-0.77
Upgrade
Levered Free Cash Flow
-2.34-1.11-3.67-3.8-0.83-1.37
Upgrade
Unlevered Free Cash Flow
-2.34-1.11-3.67-3.8-0.82-1.36
Upgrade
Change in Working Capital
0.120.12-1.031.47-1.080.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.